Table II.

Summary of single nucleotide polymorphisms (SNPs) and haplotypes present in SIT Trial participants.

Number	Position*	SNP	Alleles	MAF**
1	chr11:5246000	rs11036351	[C/T]	T (0.32)
2	chr11:5258162	rs4320977	[A/G]	G (0.23)
3	chr11:5263853	rs16912210	[A/G]	G (0.21)
4	chr11:5271671	rs2855039	[A/G]	A (0.10)
5	chr11:5276169	rs7482144	[A/G]	A (0.09)
Haplotype	Genotype***	Frequency
H1	CAAGG	0.665
H2	TGGGG	0.202
H3	TAAAA	0.094
Other		0.040

^*Genome Reference Consortium GRCh37 chromosomal coordinates.

^**Observed minor allele frequency.

^***Haplotype estimated with PHASE Version 2.1 using 5 SNPs spanning the HBB cluster. The three most common resulting five-SNP haplotypes were named H1, H2, and H3 in order of their prevalence in this population.